EDITOR-IN-CHIEF
Dr Tim Hillard
Consultant Gynaecologist and Urogynaecologist, University Hospitals Dorset, Poole, UK
Dr Hillard has disclosed that over the last 12 months he has received consultancy fees from Astellas. He has no active participation or any financial interest in any pharma companies.
ASSOCIATE EDITORS
Antonio Cano
Full Professor of Obstetrics and Gynecology at the University of Valencia, Spain, and Head of the Women’s Health Department at the Research Institute INCLIVA in Valencia.
Professor Cano has no conflicts of interest or disclosures.
Peter Chedraui, MD, PhD
Research Professor at the Escuela de Posgrado en Salud of the Universidad Espíritu Santo, Samborondón, Ecuador
Dr Chedraui has no conflicts of interest or disclosures.
Dr Rakibul Islam, MPH, PhD
School of Public Health & Preventive Medicine, Monash University, Australia
Dr Islam has no conflict of interest or disclosures.
James H. Pickar, MD, FACOG
Adjunct Associate Professor, Obstetrics and Gynaecology, Columbia University Medical Center, New York, NY, USA
Adjunct Professor of Obstetrics and Gynecology, KMITL Faculty of Medicine, Bangkok, Thailand
Dr Pickar has no conflicts of interest or disclosures.
Tevfik Yoldemir Prof MD BSc MA PhD
Professor of Obstetrics and Gynecology, Marmara University School of Medicine; Professor of Reproductive Medicine and Infertility, Marmara University Institute of Health Sciences, Istanbul, Turkey
Dr Yoldemir has no conflict of interest or disclosures.
Qi Yu, MD
Professor and Vice Director. Department of Obstetrics and Gynecology. Peking Union Medical College Hospital. Beijing. People´s Republic of China
Dr Yu has disclosed that he is the recipient of sponsorship funding to attend meetings on behalf of and is a member of the speakers´bureaux for Bayer, Merck, Wyeth, Solvay and MSD; he is a recipient of research/grant funding from Eli-Lilly, Merck and Daiichi Sankyo.
EDITORIAL BOARD
Farook Al-Azzawi, MA(Cantab), PhD, FRCOG
Gynaecology Research Unit, University Hospitals of Leicester, UK
Mr Al-Azzawi has disclosed that he has received educational grants and sponsorship funding to attend meetings on behalf of Procter & Gamble, Servier, Solvay and Wyeth.
Peter Alexandersen, MD
Center for Clinical and Basic Research (CCBR), Denmark
Dr Alexandersen has no conflict of interest or disclosures
Camil Castelo-Branco, MD, PhD
Professor of Gynecology & Obstetrics, University of Barcelona; Senior Consultant Physician, Clinic Institute of Gynecology, Obstetrics & Neonatology; Hospital Clínic, Barcelona, Spain
Professor Castelo-Branco has disclosed that he is a recipient of research/grant funding from, is a consultant/advisor to and is a member of the speakers’ bureaux for: Amgen (Sp), Servier (Sp), Pierre-Fabre (Sp), Schering Plough (Sp), Isdin, Esteve, Eli Lilly and Daiichi Sankyo.
Dr Aila Collins
Associate Professor at the Section of Psychology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
Professor Collins has no conflict of interest or disclosures.
Susan R. Davis, MB BS, FRACP, PhD, FAHMS
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Professor Davis has disclosed that she has received honoraria as a speaker from Lawley Pharmaceuticals, Pfizer Pharmaceuticals and Besins Healthcare and has been an investigator for Lawley Pharmaceuticals.
Tobias J. de Villiers, MBChB, MMed(O&G), MRCOG, FCOG(SA)
Consultant Gynaecologist, Panorama MediClinic and Department of Obstetrics & gynecology, University of Stellenbosch, Cape Town, South Africa
Dr de Villiers has disclosed that he is an investigator in clinical trials sponsored by MSD, Pfizer and Eli Lilly. He is presently on the advisory boards of Novartis(SA), Adcock Ingram, and Servier.
Anna Fenton, BHB, MBChB, PhD, FRACP
Endocrinolgist, Christchurch Women´s Hospital, University of Otago School of Medicine, Christchurch, New Zealand
Dr Fenton has disclosed that she is or has been a recipient of research/grant funding from, a consultant/advisor to, and a member of speakers´bureaux for: Pfizer/Wyeth, Merck Sharpe and Dohme, Bayer Schering, Eli-Lilly, GlaxoSmithKline, Sanofi-Aventis and Novartis.
Professor Marco Gambacciani
Department of Obstetrics & Gynecology, Ospedale S. Chiara, University of Pisa, Pisa, Italy
Professor Gambacciani has no conflict of interest or disclosures.
Ulysee J. Gaspard, MD, PhD
Honorary Professor and Head, Department of Gynaecology, Sart Tilman University Hospital, University of Liege, Liege, Belgium; Senior Consultant Physician, University Clinics L.Brull, University of Liege, Belgium
Professor Gaspard has disclosed that he is a consultant/advisor to Mithra Pharmaceuticals.
Prof. Andrea R. Genazzani
Department of Reproductive Medicine and Child Development, Divisione Ginecologia e Ostetricia, Pisa, Italy
Steven R. Goldstein, MD
Professor of Obstetrics and Gynecology, New York University School of Medicine; Director of Gynecologic Ultrasound; Co-Director of Bone Densitometry, New York University Langone Medical Center, New York, USA
Professor Goldstein has disclosed that he is a Director for Sonosite, Inc., is on the Gyn Advisory Board for Amgen, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk, is a Consultant for Cook ObGyn and Phillips Ultrasound; and is a member of the speakers’ bureaux for Eli Lilly & Co, Procter & Gamble, and Warner Chilcott.
Anne Gompel, MD, PhD
Head of the Gynecology Endocrinology Unit, Hôtel-Dieu Hospital, Paris; Professor of Reproductive Endocrinology, Paris Descartes University, member of the INSERM UMRS 938 Saint Antoine CDR, Paris , France
Professor Gompel has disclosed that she is a recipient of research/grant funding from Novartis, HRA Pharma, Azko/Organon, Besins. She is a member of the Advisory board of EURAS HRT with an unrestricted grant from Bayer Schering. She is a consultant for Jerini-Shire Laboratory.
Prof. Franco Guidozzi
Professor, Netcare Park Lane Hospital, Johannesburg, South Africa
Professor Guidozzi has no conflict of interest or disclosures.
Victor W. Henderson, MD, MS
Professor of Health Research & Policy (Epidemiology) and of Neurology & Neurological Science, Stanford University, Stanford, California, USA
Professor Henderson has disclosed that he is a recipient of research/grant funding from the National Institutes of Health.
Nicole Jaff, PhD (South Africa), NCMP (USA)
Department of Chemical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Doctor Jaff has no conflict of interest or disclosures.
Dr Elaine Jolly
Shirley E. Greenberg Women´s Health Research Centre, Ottawa Hospital, Canada
Dr Jessica Kasza, School of Public Health and Preventive Medicine, Monash University, Melbourne, Asutralia
Sheryl Kingsberg, PhD
Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Rogerio A. Lobo, MD, FACOG
Professor of Obstetrics and Gynecology, Columbia University, New York, New York
Professor Lobo has nothing to disclose.
Professor Pauline Maki
Departments of Psychiatry, Psychology and OB/GYN at the University of Illinois at Chicago, USA
Professor Maki has disclosed that she is a consultant for AbbVie, Astellas, Bayer, Johnson & Johnson, Pfizer.
Miss Jo Marsden
Consultant Breast Surgeon, King´s college Hospital, UK
Associate Professor Tomi Mikkola
Women´s Hospital, University of Helsinki, Finland
Alfred O. Mueck, MD, PharmD, PhD
Professor of Clinical Pharmacology and Experimental Endocrinology, Head of Centre of Women’s Health South Germany (BW), Medical Director of Department of Endocrinology and Menopause; University Women’s Hospital of Tuebingen, Germany
Professor Mueck has disclosed that he is a consultant/advisor to Bayer-Schering, Novartis, Novo Nordisk, Procter & Gamble, Schering-Plough/Merck Sharpe & Dohme and Solvay and is also a member of the speakers’ bureaux of these companies. He is a recipient of research/grant funding from Bayer-Schering, Dr.Kade Pharma, Novartis, Novo Nordisk and Schering-Plough/Merck Sharpe & Dohme.
Rossella Nappi
Research Center for Reproductive Medicine, Department of Morphological, Eidological & Clinical Sciences, University of Pavia, Pavia, Italy
Professor Nappi has disclosed that during the past 2 years, she has had financial relationships with Bayer-Schering Pharma, Boehringer Ingelheim, Merck-Theramex, Novo Nordisk, Procter & Gamble Pharmaceuticals, Schering-Plough/Organon.
Santiago Palacios, MD, PhD
Director of the Palacios Institute of Women’s Health, Madrid, Spain
Dr Palacios has disclosed that he is a recipient of research/grant funding from, is a consultant/advisor to, and/or is a lecturer for: Bayer-Schering, Novo Nordisk, Servier, Lilly, Daiichi-Sankyo, Sanofi-Aventis, MSD, Warner Chilcott Iberia, Pfizer-Wyeth, Amgen, Astra-Zeneca and Arkochim.
Mr Nick Panay, BSc, MRCOG, MFSRH
Queen Charlotte´s & Chelsea Hospital, London, UK
Mr Panay has disclosed that he has acted in advisory capacity, performed research and/or lectured on behalf of the following companies: Baxter, Bayer Schering, Eli Lilly, Galen, Janssen Cilag, Merck, Novo Nordisk, Novogen, Organon, Orion, Proctor & Gamble, Se-cure, Servier, Shire, Solvay, Storz, and Wyeth.
Faustino Perez Lopez, MD, PhD
Professor of Obstetrics and Gynaecology, University of Zaragoza and Lozano Blesa University Hospital, Zaragoza, Spain
Dr Perez Lopezhas disclosed that he has no conflict of interest.
Amos Pines
Specialist in Internal Medicine, working in the Tel-Aviv Medical Center, which is affiliated to the Tel-Aviv University School of Medicine
Professor Pines has disclosed that he has no conflict of interest, except for an indirect one, being a consultant for a local, Israeli distributor that represents about 20 international pharma companies with niche products in all fields of medicine.
JoAnn V. Pinkerton, MD
Professor of Obstetrics and Gynecology, Director, Midlife Health Division, University of Virginia, Charlottesville, Virginia, USA
Professor Pinkerton has disclosed that she is or has been Consultant/Advisory Board for Eli Lilly, Teva, Novo Nordisk, Amgen and Wyeth. She is currently involved in multicenter clinical trials as principal investigator for Wyeth and Pfizer. She serves on the Data Safety Monitoring Board for Boehringer Ingelheim. In addition, she serves as Past President and board member for the North American Menopause Society, is a member of the Council on Hormone Foundation for the Endocrine Society and a board member for the National Women’s Health Resource Center.
Giuseppe M. C. Rosano, MD, PhD
Director, Centre for Clinical & Basic Research, IRCCS San Raffaele Roma, Rome, Italy
Professor Rosano has nothing to disclose.
Serge Rozenberg, MD
Professor of Obstetrics and Gynaecology, Université Libre de Bruxelles (Free University Brussels), Belgium
Professor Rozenberg has disclosed that he is a recipient of research grant/member of the advisory boards of Amgem, and Merck Sharpe & Dohme.
Professor Dr Xiangyan Ruan, MD, PhD (Beijing ,China)
Gynecologist for Menopause and Endocrinology, Department of Gynecological Endocrinology, Obstetrics & Gynecology Hospital, Capital Medical University, Beijing, China
Professor Ruan has no conflict of interest or disclosures.
Mr Michael M. Savvas
Senior Consultant Gynaecologist and Specialist in the Management of the Menopause at The London PMS and Menopause Centre, 46 Wimpole Street, London W18 8SD, UK
Mr Savvas has no conflict of interest or disclosures.
Hermann P. G. Schneider, MD, PhD, FRAM
Emeritus Professor of Obstetrics & Gynecology, Department of Obstetrics & Gynecology, University of Muenster Medical School, Muenster, Germany
Professor Schneider has nothing to disclose.
Dr Duru Shah, MD FRCOG FCPS FICS FICOG FICMCH DGO DFP
Ex-Professor Obstetrics & Gynecology, Grant Medical College, Nowrosjee Wadia Maternity Hospital, University of Mumbai. Post Graduate Guide for Diplomate of National Board, Jaslok Hospital & Research Center, Mumbai, India
Dr Shah has disclosed that she is the Chairman of the Advisory Board for Wyeth Ltd. (subsidiary Pfizer Inc.).
Dr Marla Shapiro
Department of Family and Community Medicine, University of Toronto, Canada
Prof. Lee P. Shulman, MD, PhD
Division of Gynecology and Gynecology-Clinical Genetics, Northwestern University´s Feinberg School of Medicine, Chicago, USA
Prof Frank Z. Stanczyk, PhD
Professor of Research, Obstetrics and Gynecology and Preventive Medicine, Director, Reproductive Endocrine Research Laboratory, USC Keck School of Medicine, Los Angeles, USA
John C. Stevenson, MB BS, FRCP, FESC, MFSEM
Reader and Consultant Metabolic Physician/Honorary Principal Research Fellow, National Heart & Lung Institute, Imperial College London, Royal Brompton Hospital, London, UK
Dr Stevenson has disclosed that he is the recipient of research/grant funding from Schering Plough and Wyeth/Pfizer; is a consultant to Wyeth/Pfizer and lecturer for Bayer, Meda and Merck/Theramex.
Cynthia Stuenkel
University of California, San Diego, USA
Delfin A. Tan, MD, FPOGS, FPSREI, FPSGE
Head, Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, St. Luke's Medical Center, Quezon City, Philippines
Dr Tan has disclosed that he is currently advisor to Bayer Schering Pharma, has received research grants from Bayer Schering Pharma and Wyeth-Ayerst Pharmaceuticals, has received sponsorships to attend meetings from Bayer Schering Pharma, Eli Lilly, and AstraZeneca, and has given lectures for Bayer Schering Pharma, AstraZeneca, Eli Lilly, and Takeda.
Wulf Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS
Professor Emeritus, Case Western Reserve University; Consultant, Gynecology and Women´s Health, The Cleveland Clinic, Ohio, USA
Paulina Villaseca
Associate Professor, Gynecologist, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Professor Villaseca has disclosed that she has lectured for Novartis and for Eli Lilly.
Amanda Vincent, MBBS, B Med Sci (Hons), PhD, FRACP
Consultant Endocrinologist, Menopause Unit, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; Senior Post-doctoral Research Fellow, Jean Hailes Foundation Clinical Research Unit, School of Public Health and Preventative Medicine, Monash University, Clayton, Victoria, Australia
Dr Vincent has disclosed that she is the recipient of research/grant funding from Organon and Ralph Lauren and has been a member of the speakers’ bureau for Organon.
Dr Salvatore Giovanni Vitale, MD, Ph.D
Unit of Gynecology and Obstetrics, Department of General Surgery and Medical Surgical Specialities, University of Catania, Italy
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})